Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06481891

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Led by Lexicon Pharmaceuticals · Updated on 2026-02-27

500

Participants Needed

107

Research Sites

96 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main purpose of the study is to determine the changes in symptoms and functional limitations in participants with symptomatic hypertrophic cardiomyopathy (HCM) treated with sotagliflozin as compared to placebo.

CONDITIONS

Official Title

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ CSS) less than 85.
  • New York Heart Association (NYHA) functional class II or III.
  • Diagnosed hypertrophic cardiomyopathy (HCM) with left ventricular wall thickness ≥ 15 mm, or ≥ 13 mm with family history.
  • For obstructive HCM, left ventricular outflow tract peak gradient ≥ 30 mm Hg at rest or with Valsalva.
  • For nonobstructive HCM, left ventricular outflow tract peak gradient less than 30 mm Hg at rest and with Valsalva.
  • Left ventricular ejection fraction (LVEF) ≥ 50%, or ≥ 55% if on cardiac myosin inhibitor.
  • Stable cardiac myosin inhibitor dose for at least 3 months before screening, with no planned dose increase during the trial.
  • Stable background heart medication (beta-blockers, calcium channel blockers, ACE inhibitors, ARBs, diuretics) for at least 1 month before screening.
Not Eligible

You will not qualify if you...

  • Received any sodium glucose co-transporter 2 (SGLT2) inhibitor treatment within 8 weeks before screening.
  • Previous intolerance to any SGLT2 inhibitor.
  • Any prior treatment with sotagliflozin.
  • Current use of thiazolidinediones or digoxin.
  • Current or planned participation in another interventional clinical trial, or participation in one within 45 days before screening.
  • Known cardiac storage or infiltrative diseases like Fabry disease, amyloidosis, or Noonan syndrome with left ventricular hypertrophy.
  • History of unexplained fainting (syncope) within 6 months before screening.
  • History of sustained ventricular tachyarrhythmia lasting more than 30 seconds or appropriate ICD discharge within 6 months before screening.
  • Atrial fibrillation not anticoagulated for at least 4 weeks before screening or not adequately rate controlled within 3 months before screening.
  • Planned septal reduction therapy during the study or septal reduction therapy completed less than 3 months before screening.
  • Cardiac surgery, coronary intervention, or cardiac device implantation within 3 months before screening or planned during the study.
  • Presence of cardiac resynchronization therapy device.
  • Acute coronary syndrome within 2 months before screening.
  • Stroke or heart attack within 6 months before screening.
  • Hospitalization for heart failure or arrhythmia within 4 weeks before screening.
  • Moderate or severe aortic valve stenosis at screening.
  • Current angina or significant ischemia from unstable coronary disease as judged by the investigator.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 107 locations

1

Lexicon Investigational Site (4041)

Phoenix, Arizona, United States, 85054

Actively Recruiting

2

Lexicon Investigational Site (4037)

Scottsdale, Arizona, United States, 85260

Actively Recruiting

3

Lexicon Investigational Site (4012)

Los Angeles, California, United States, 90048

Actively Recruiting

4

Lexicon Investigational Site (4035)

Pomona, California, United States, 91767

Actively Recruiting

5

Lexicon Investigational Site (4044)

San Francisco, California, United States, 94143

Actively Recruiting

6

Lexicon Investigational Site (4046)

Jacksonville, Florida, United States, 32224

Actively Recruiting

7

Lexicon Investigational Site (4034)

Orlando, Florida, United States, 32804

Actively Recruiting

8

Lexicon Investigational Site (4018)

Atlanta, Georgia, United States, 30322

Actively Recruiting

9

Lexicon Investigational Site (4033)

Evanston, Illinois, United States, 60208

Actively Recruiting

10

Lexicon Investigational Site (4036)

Merrillville, Indiana, United States, 46410

Actively Recruiting

11

Lexicon Investigational Site (4021)

Baltimore, Maryland, United States, 21218

Actively Recruiting

12

Lexicon Investigational Site (4016)

Boston, Massachusetts, United States, 02115

Actively Recruiting

13

Lexicon Investigational Site (4042)

Boston, Massachusetts, United States, 02118

Actively Recruiting

14

Lexicon Investigational Site (4028)

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

15

Lexicon Investigational Site (4038)

Grand Rapids, Michigan, United States, 49525

Actively Recruiting

16

Lexicon Investigational Site (4027)

Rochester, Minnesota, United States, 55905

Actively Recruiting

17

Lexicon Investigational Site (4013)

St Louis, Missouri, United States, 63110

Actively Recruiting

18

Lexicon Investigational Site (4029)

Morristown, New Jersey, United States, 07960

Actively Recruiting

19

Lexicon Investigational Site (4039)

Manhasset, New York, United States, 11030

Actively Recruiting

20

Lexicon Investigational Site (4043)

New York, New York, United States, 10016

Actively Recruiting

21

Lexicon Investigational Site (4026)

Morrisville, North Carolina, United States, 27560

Actively Recruiting

22

Lexicon Investigational Site (4031)

Cincinnati, Ohio, United States, 45219

Actively Recruiting

23

Lexicon Investigational Site (4017)

Cleveland, Ohio, United States, 44195

Actively Recruiting

24

Lexicon Investigational Site (4024)

Tulsa, Oklahoma, United States, 74104

Actively Recruiting

25

Lexicon Investigational Site (4015)

Portland, Oregon, United States, 97239

Actively Recruiting

26

Lexicon Investigational Site (4011)

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

27

Lexicon Investigational Site (4019)

Germantown, Tennessee, United States, 38138

Actively Recruiting

28

Lexicon Investigational Stie (4014)

Houston, Texas, United States, 77030

Actively Recruiting

29

Lexicon Investigational Site (4032)

Charlottesville, Virginia, United States, 22908

Actively Recruiting

30

Lexicon Investigational Site (4010)

Seattle, Washington, United States, 98195

Actively Recruiting

31

Lexicon Investigational Site (4022)

Marshfield, Wisconsin, United States, 54449

Actively Recruiting

32

Lexicon Investigational Site (4040)

Milwaukee, Wisconsin, United States, 53215

Actively Recruiting

33

Lexicon Investigational Site (5016)

Santa Rosa, La Pampa Province, Argentina, L6304BWE

Actively Recruiting

34

Lexicon Investigational Site (5012)

Rosario, Santa Fe Province, Argentina, 2000

Actively Recruiting

35

Lexicon Investigational Site (5015)

Corrientes, Argentina, W3400CDS

Actively Recruiting

36

Lexicon Investigational Site (5010)

Córdoba, Argentina, 5002

Actively Recruiting

37

Lexicon Investigational Site (5013)

Córdoba, Argentina, X5000AAX

Actively Recruiting

38

Lexicon Investigational Site (5011)

Salta, Argentina, 4400

Actively Recruiting

39

Lexicon Investigational Site (5014)

Santa Fe, Argentina, 3000

Actively Recruiting

40

Lexicon Investigational Site (1012)

Genk, Belgium, 3600

Actively Recruiting

41

Lexicon Investigational Site (5114)

Salvador, Estado de Bahia, Brazil, 40170-130

Actively Recruiting

42

Lexicon Investigational Site (5110)

Campinas, São Paulo, Brazil, 13060-080

Actively Recruiting

43

Lexicon Investigational Site (5112)

Recife, Brazil, 52051-380

Actively Recruiting

44

Lexicon Investigational Site (5115)

São Paulo, Brazil, 04039-000

Actively Recruiting

45

Lexicon Investigational Site (1112)

Rousse, Bulgaria, 7013

Actively Recruiting

46

Lexicon Investigational Site (1111)

Sofia, Bulgaria, 1407

Actively Recruiting

47

Lexicon Investigational Site (1215)

Krapinske Toplice, Croatia, 49217

Actively Recruiting

48

Lexicon Investigational Site (1212)

Opatija, Croatia, 51410

Actively Recruiting

49

Lexicon Investigational Site (1210)

Rijeka, Croatia, 51000

Actively Recruiting

50

Lexicon Investigational Site (1213)

Zagreb, Croatia, 10000

Actively Recruiting

51

Lexicon Investigational Site (1311)

Brno, Czechia, 602 00

Actively Recruiting

52

Lexicon Investigational Site (1310)

Prague, Czechia, 128 08

Actively Recruiting

53

Lexicon Investigational Site (1312)

Ústí nad Labem, Czechia, 400 11

Actively Recruiting

54

Lexicon Investigational Site (1514)

Chambray-lès-Tours, France, 37170

Actively Recruiting

55

Lexicon Investigational Site (1511)

Marseille, France, 13005

Actively Recruiting

56

Lexicon Investigational Site (1513)

Paris, France, 75651

Actively Recruiting

57

Lexicon Investigational Site (1510)

Poitiers, France, 86021

Actively Recruiting

58

Lexicon Investigational Site (1512)

Rennes, France, 35033

Actively Recruiting

59

Lexicon Investigational Site (1515)

Toulouse, France, 31059

Actively Recruiting

60

Lexicon Investigational Site (1611)

Tbilisi, Georgia, 0112

Actively Recruiting

61

Lexicon Investigational Site (1610)

Tbilisi, Georgia, 0131

Actively Recruiting

62

Lexicon Investigational Site (1612)

Tbilisi, Georgia, 0144

Actively Recruiting

63

Lexicon Investigational Site (1613)

Tbilisi, Georgia, 0186

Actively Recruiting

64

Lexicon Investigational Site (2813)

Berlin, Germany, 13353

Actively Recruiting

65

Lexicon Investigational Site (2812)

Hamburg, Germany, 22041

Actively Recruiting

66

Lexicon Investigational Site (2811)

Leipzig, Germany, 04289

Actively Recruiting

67

Lexicon Investigational Site (2810)

München, Germany, 80336

Actively Recruiting

68

Lexicon Investigational Site (1710)

Budapest, Hungary, 1122

Actively Recruiting

69

Lexicon Investigational Site (1711)

Pécs, Hungary, 7624

Actively Recruiting

70

Lexicon Investigational Site (1712)

Szeged, Hungary, 6725

Actively Recruiting

71

Lexicon Investigational Site (1713)

Zalaegerszeg, Hungary, 8900

Actively Recruiting

72

Lexicon Investigational Site (7017)

Be’er Ya‘aqov, Israel, 7033001

Actively Recruiting

73

Lexicon Investigational Site (7013)

Haifa, Israel, 3109601

Actively Recruiting

74

Lexicon Investigational Site (7014)

Haifa, Israel, 3339419

Actively Recruiting

75

Lexicon Investigational Site (7015)

Holon, Israel, 5822012

Actively Recruiting

76

Lexicon Investigational Site (7011)

Jerusalem, Israel, 9112001

Actively Recruiting

77

Lexicon Investigational Site (7016)

Petah Tikva, Israel, 4941492

Actively Recruiting

78

Lexicon Investigational Site (7012)

Ramat Gan, Israel, 5265601

Actively Recruiting

79

Lexicon Investigational Site (7019)

Tel Aviv, Israel, 6423906

Actively Recruiting

80

Lexicon Investigational Site (1814)

Arezzo, Italy, 52100

Actively Recruiting

81

Lexicon Investigational Site (1811)

Brescia, Italy, 25123

Actively Recruiting

82

Lexicon Investigational Site (1813)

Naples, Italy, 80131

Actively Recruiting

83

Lexicon Investigational Site (2114)

Lodz, Poland, 91-347

Actively Recruiting

84

Lexicon Investigational Site (2113)

Lodz, Poland, 92-213

Actively Recruiting

85

Lexicon Investigational Site (2115)

Oświęcim, Poland, 32-600

Actively Recruiting

86

Lexicon Investigational Site (2110)

Wroclaw, Poland, 50-981

Actively Recruiting

87

Lexicon Investigational Site (2210)

Braga, Portugal, 4710-243

Actively Recruiting

88

Lexicon Investigational Site (2213)

Faro, Portugal, 8000-386

Actively Recruiting

89

Lexicon Investigational Site (2211)

Lisbon, Portugal, 1350-352

Actively Recruiting

90

Lexicon Investigational Site (2215)

Lisbon, Portugal, 1500-650

Actively Recruiting

91

Lexicon Investigational Site (2218)

Lisbon, Portugal, 1649-035

Actively Recruiting

92

Lexicon Investigational Site (2216)

Lisbon, Portugal, 1998-018

Actively Recruiting

93

Lexicon Investigational Site (2217)

Porto, Portugal, 4200-319

Actively Recruiting

94

Lexicon Investigational Site (2910)

Baloteşti, Romania, 077015

Actively Recruiting

95

Lexicon Investigational Site (2913)

Suceava, Romania, 720049

Actively Recruiting

96

Lexicon Investigational Site (2911)

Târgu Mureş, Romania, 540124

Actively Recruiting

97

Lexicon Investigational Site (2912)

Târgu Mureş, Romania, 540143

Actively Recruiting

98

Lexicon Investigational Site (2312)

Belgrade, Serbia, 11000

Actively Recruiting

99

Lexicon Investigational Site (2314)

Belgrade, Serbia, 11000

Actively Recruiting

100

Lexicon Investigational Site (2311)

Belgrade, Serbia, 11040

Actively Recruiting

101

Lexicon Investigational Site (2313)

Belgrade, Serbia, 11040

Actively Recruiting

102

Lexicon Investigational Site (2310)

Niš, Serbia, 18108

Actively Recruiting

103

Lexicon Investigational Site (2510)

Stockholm, Sweden, 17164

Actively Recruiting

104

Lexicon Investigational Site (2712)

Glasgow, United Kingdom, G51 4TF

Actively Recruiting

105

Lexicon Investigational Site (2713)

Leicester, United Kingdom, LE3 9QP

Actively Recruiting

106

Lexicon Investigational Site (2710)

Liverpool, United Kingdom, L14 3PE

Actively Recruiting

107

Lexicon Investigational Site (2711)

London, United Kingdom, EC1M 6BQ

Actively Recruiting

Loading map...

Research Team

T

Tracy Newbold

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here